spacer
home > epc > spring 2002 > industry-specific supply chain software - the sugar that helps the medicine go down
PUBLICATIONS
European Pharmaceutical Contractor

Industry-Specific Supply Chain Software - The Sugar that Helps the Medicine Go Down

Matters such as meeting institutional requirements,item restrictions, traceability, speed and accuracy, storage, despatch, customer service, are very specific needs for the pharmaceutical industry, and the number one deliverables for any pharmaceutical company looking for software. For pharmaceutical distribution there is the added challenge of incredibly large transactions volumes coupled with demanding time constraints.
Pharmaceutical distribution is among the most advanced areas within distribution and supply chain management. It is only recently that integrated software covering the full spectrum of the pharmaceutical industry's sophisticated requirements has reached the market.

Speed and Security are of the Essence

The processing time for the distribution of pharmaceuticals is very short, a dominant feature being fast order cycles. Leading Swiss pharmaceuticals distributor Galexis, for example, accomplishes delivery to a multitude of recipients, with no more than three hours passing between the order being sent electronically by the customer, to delivery at their doorstep.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Andre Grigjanis, Managing Director, Global Competence Centre for IBS Pharma, and John O'Connor, Vice President Global Sales, the IBS Group

Andre Grigjanis is the driving force behind the IBS Group's vertical industry software product, IBS Pharma. During his 10 years as Managing Director of the German subsidiary of IBS (International Business Systems), he has built upon the company's focus on pharmaceutical distribution.

John O'Connor is Vice President Global Sales of the IBS Group, and Area Manager for IBS' operations in Germany and Switzerland. Before joining IBS Group management, he was Managing Director of IBS UK.

spacer
Andre Grigjanis
spacer
spacer
spacer
John O'Connor
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement